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A rare case of squamous cell carcinoma ex pleomorphic adenoma in maxillary sinus is 
presented. The patient is a 50-year-old woman presenting with a slow-progressive swelling in 
left side of her face that she has noticed 2 years earlier. The lesion was not painful and caused 
asymmetry and mild exophthalmos. Microscopic examination revealed that the tumor was 
composed of two components; partly of a pleomorphic adenoma and partly of a squamous 
cell carcinoma. Immunohistochemical examination for Ki-67 and SMA and mucicarmin 
staining were also done and confirmed the diagnosis of carcinoma ex pleomorphic adenoma. 
There is no evidence of recurrence 12 months after operation. 
 
Keywords: Pleomorphic adenoma, Malignant transformation, Squamous cell carcinoma, 
Case report 
Introduction 
Among different salivary gland tumors, 
carcinoma ex pleomorphic adenoma (Ca 
ex PA) accounts for approximately 3.6% 
(1). It constitutes 6.2% of all pleomorphic 
adenoma (PA) and 11.7% of all malignant 
salivary gland neoplasms (1, 2). 
Furthermore, the risk of malignant 
transformation in PAs in the first five 
years after evolution of the lesion is 1.6% 
(3). Car ex PA is defined as an epithelial 
malignant transformation within a primary 
or previous PA, and is often considered as 
a diagnostic challenge for the pathologists 
and clinicians, since it is difficult to 
diagnose this entity pre-operatively due to 
unspecific clinical presentation [4, 5]. In 
fact, most of Ca ex PA tumors shows 
clinical presentation similar to PA. It 
means that they can be asymptomatic and 
not invasive in gross examination. 
However, early diagnosis and accurate 
surgical intervention is important to 
increase the patients' survival rates because 
of aggressiveness and destructive behavior 
of this tumor (1-6). WHO states that the 
malignant component of Ca ex PA is 
mostly adenocarcinoma, not otherwise 
specified (NOS), and sometimes salivary 
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duct carcinoma (SDC), undifferentiated 
carcinoma, adenoid cystic carcinoma, or 
mucoepidermoid carcinoma (7).  
We discuss the presentation, 
histopathologic picture, and management 
of a rare case of squamous cell carcinoma 
(SCC) ex pleomorphic adenoma 
originating in the maxillary sinus.  
Case report  
A 50-year-old woman presented to our 
clinic with a chief complaint of asymmetry 
due to a long-standing swelling on the left 
side of her face which had first appeared 2 
years earlier. There were no other 
symptoms such as pain and facial 
paralysis. The swelling was bony hard and 
non-tender in palpation. There was also a 
mild exophthalmos without pain and visual 
disturbance.  Clinical examination of 
cervical lymph nodes showed no abnormal 
findings.  Waters radiograph revealed a 
space-occupying destructive mass filling 
the left antrum completely. Computed 
tomography scans depicted a large ill- 
defined mass in left maxillary sinus 
causing destruction of medial, infraorbital 
and floor of the sinus with extention to the 
left orbital region (Figures 1, 2 and 3).  
 
 
Figure 1. Waters view. Complete opacification of 
left maxillary sinus. 
 
 
Figure 2. Computed tomography. Axial view; a 
destructive lesion in left antrum. 
 
Figure 3. Computed tomography. Cronal view; 
distruction of palate, lateral nasal wall and 
maxillary sinus. 
 
Incisional biopsy of the lesion was 
performed and histopathological 
examination revealed a case of 
pleomorphic adenoma in a hyalinizing 
fibrotic and chondromyxoid stroma with 
the malignant areas of carcinomatous 
component consisting dysplastic squamous 
cells which exhibited large nuclei with 
pleomorphic shapes, prominent nucleoli 
and few abnormal mitotic figures.  Focal 
areas of calcification were present. 
Moreover, clear cells arranged in small 
nests or as individual cells intermixed with 
squamous cells were also detected (Figures 
4, 5 and 6). 





Figure 4. Histopathologic features of PA 




Figure 5. Squamous cell carcinoma cell component 




Figure 6. Extensive hyalinization and areas of 
calcification close to the malignant cells 
(Hematoxylin-Eosin, original magnification ×100). 
 
Mucicarmin staining was done and all 
clear cells were negative, therefore, the 
diagnosis of mucoepdermoid carcinoma 
was ruled out for the malignant component 
of the tumor. Immunohistochemical 
staining was positive for ki-67 in more 
than 60% of squamous cells whereas 
pleomorphic adenoma component was 
negative for this marker. Additional 
immunohistochemical staining was also 
conducted. The clear cells in malignant 
component were negative for SMA, but 
clear cells of PA showed reactivity for 
SMA which proved the myoepithelial 
origin of these cells.  These findings were 
consistent with the diagnosis of squamous 
cell carcinoma ex pleomorphic adenoma 
for this case.  
Discussion  
Based on World Health Organization 
classification in 2005, Ca ex PA is the 
most common malignant change in PA and 
accounts for 11.7% of salivary 
malignancies (3, 8).  Malignant mixed 
tumors are divided into three categories: 1. 
carcinoma ex pleomorphic adenoma, 2. 
Carcinosarcoma and 3. metastasizing 
mixed tumor. (9) 
Although PA mostly arise in the parotid 
gland or minor salivary glands, it is also 
the most frequent tumor of the 
seromucinous glands of other organs such 
as nasal cavity, sinuses and trachea (10). 
Any type of carcinoma can arise in a PA, 
but adenocarcinoma NOS and salivary 
duct carcinoma are the most common 
types. (4, 5, 11). The frequency of 
malignant components of Ca ex-PA is 43–
90% in adenocarcinoma, not otherwise 
specified (NOS), 10–34% in SDC, and 
rare in mucoepidermoid carcinoma and 
SCC (9, 11). In sinonasal tract, Ca ex PA 
is considered as the least common 
malignancy (12). 
Generally, there is a history of a painless 
and slow-growing mass which start to 
enlarge rapidly over a short period of time 
(13). Patients usually present with signs 
and symptoms indicating malignant 
transformation (e.g., facial nerve palsy, 
pain, skin perforation and trismus). 
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Approximately 23% to 40% of cases 
shows facial nerve weakness or palsy. (14) 
Cellular pleomorphism, cellular anaplasia, 
atypical mitosis, destruction of normal 
tissues, invasiveness and abnormal 
architectural patterns are defined by Gnepp 
and Wenig as the criteria of malignancy in 
a PA. (15). Gerughty et al. suggested that 
microscopic evidence of an invasive 
growth pattern, neural or vascular 
invasion, focal areas of calcification and 
necrosis are related to a poor prognosis. 
(16) In agreement with Gnepp and Wenig 
and according to the criteria proposed by 
Gerughty, this patient is definitely a case 
of carcinomatous transformation in the 
PA. 
 Several cases of Ca ex PA have been 
described in previous reports, (17-21) but 
SCC ex pleomorphic adenoma is appear to 
be rare as mentioned by Peel and Gnepp 
(22). Seifert et al. recognized SCC 
components in 4 out of 38 (10%) Ca-ex-
PA patients (23). In contrast, Lewis et al. 
(11) found no cases with SCC components 
among 73 patients, nor did Matsubayashi 
et al. among 1010 cases. (9). In addition, 
in 37 cases of Car ex PA reported by 
Tortoledo et al. (24), no malignant 
components were diagnosed as SCC.  A 
case of Ca ex PA with the presence of 
SCC and salivary duct carcinoma was 
reported by Nakamori et al. (25). 
Therefore, SCC as the malignant 
component of Car ex PA seems to be rare 
(25-28).  
In differential diagnosis, it is important for 
the pathologists to distinguish SCC from 
squamous cell metaplasia, as well as SCC 
from mucoepidermoid carcinoma (29, 30). 
Ki-67 staining reported by Zhu et al. as a 
useful diagnostic marker to discriminate 
between malignant and benign tumors of 
salivary gland (31).  In the current patient, 
the immunostaining of Ki-67 helped us to 
differential SCC from squamous cell 
metaplasia. Mucicarmin staining was also 
used to detect mucin cells in order to 
distinguish SCC from mucoepidermoid 
carcinoma.  
In the present case, partial maxillectomy as 
well as left eye exenteration was done. As 
achieving a complete resection with wide 
margins in the head and neck region is not 
always possible, in order to reduce the 
probability of recurrence, the primary site 
received external irradiation 
postoperatively. The patient was then 
referred to a prosthodontist to fabricate 
maxillary and midface prosthesis. There 
was no evidence of recurrence 12 months 
after operation. 
Conclusion 
This is a rare case of carcinoma ex 
pleomorphic adenoma of the antrum with 
an unusual malignant component of 
squamous cell carcinoma. The SCC 
component has originated from the 
epithelial part of PA. 
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